Clinical Trial Update: Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the safety and efficacy of paromomycin for visceral leishmaniasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Visceral Leishmaniasis

Drugs mentioned

• Paromomycin (paromomycin)

Snippet

Sponsor: PATH | Conditions: Visceral Leishmaniasis | Phase 3 | Status: COMPLETED